Edition:
United Kingdom

Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS)

600196.SS on Shanghai Stock Exchange

44.15CNY
23 Jan 2018
Change (% chg)

-- (--)
Prev Close
¥44.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
20,754,001
52-wk High
¥47.58
52-wk Low
¥24.70

Latest Key Developments (Source: Significant Developments)

Shanghai Fosun Pharmaceutical Group units receive approval for drug clinical trials
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says two Shanghai-based pharmaceutical units received drug clinical trials approval for injection FN-1501, which is mainly used for treatment of leukemia.  Full Article

Shanghai Fosun Plans U.S. JV, To Boost Capital Of Shanghai Biotech Firm
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS UNIT PLANS TO INVEST $25.5 MILLION TO SET UP JV IN THE U.S..SAYS IT PLANS TO BOOST CAPITAL OF SHANGHAI BIOTECH FIRM BY 102 MILLION YUAN ($15.68 million).  Full Article

Shanghai Fosun Pharmaceutical Group unit receives GMP certificate
Monday, 1 Jan 2018 

Jan 1 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS> ::* Says its Jiangsu unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration .* Certificate issued tablets and hard capsules manufactured by the unit and the valid period is until Dec. 25, 2022.  Full Article

Shanghai Fosun Pharmaceutical Group signs project investment framework agreement
Friday, 29 Dec 2017 

Dec 29(Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS> ::Says it signed a project investment framework agreement with Xuzhou-based economic and technological development zone management committee.  Full Article

China'S Fosun Plans $3 Billion Of Local Bond Offerings - Bloomberg‍​
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - :CHINA'S FOSUN PLANS $3 BILLION OF LOCAL BOND OFFERINGS - BLOOMBERG, CITING PEOPLE FAMILIAR WITH THE MATTER ‍​.  Full Article

Shanghai Fosun Pharmaceutical Group unit gets approval for HLX10 clinical trail
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS> ::Says its Taiwan-based controlling unit gets approval from Ministry of Health and Welfare to launch clinical trail of HLX10(Recombinant Humanized Anti-PD-1 Monoclonal Antibody), which is used for treatment of solid tumor.  Full Article

Shanghai Fosun Pharmaceutical Group's Unit Enters Capital Increase Agreement
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::UNIT ENTERS CAPITAL INCREASE AGREEMENT WITH SHAREHOLDERS OF SHANGHAI HENLIUS, OTHER INVESTORS, SHANGHAI HENLIUS​.FOSUN PHARMA INDUSTRIAL TO ACQUIRE 14.6 MILLION ADDITIONAL SHARES IN SHANGHAI HENLIUS AT RMB22.71 PER SHARE.‍OTHER INVESTORS TO BUY TOTAL OF 40.8 MILLION ADDITIONAL SHARES IN SHANGHAI HENLIUS AT RMB22.71/SHARE, FOR US$140 MILLION​.SHANGHAI HENLIUS TO ISSUE 55.4 MILLION ADDITIONAL SHARES IN CO TO UNIT, OTHER INVESTORS FOR US$190 MILLION​.  Full Article

Shanghai Fosun Pharmaceutical Unit To Raise About $190 Million By Share Issue, Signs Agreement
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS BIO-TECH UNIT SIGNS LICENSING FRAMEWORK AGREEMENT WITH JACOBSON PHARMA'S <<<2633.HK>>> UNITS.SAYS BIO-TECH UNIT AIMS TO RAISE ABOUT $190 MILLION BY ISSUING 55.4 MILLION SHARES TO CO'S UNIT, EXTERNAL INVESTORS.  Full Article

Shanghai Fosun Pharmaceutical Group unit signs cooperate agreement for senile disease special hospital
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS> ::Says its controlling unit signed cooperate agreement with a Zigong local hospital to set up a senile disease special hospital.  Full Article

Shanghai Fosun Pharmaceutical Group unit signs strategic cooperation framework agreement with government
Wednesday, 29 Nov 2017 

Nov 29(Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says co's unit Shanghai Henlius Biotech signed strategic cooperation framework agreement with local government of Songjiang District, Shanghai City.Says unit plans to set up biological medicine firm and biological medicine industrialization base in Songjiang District, Shanghai City.  Full Article